Position in LRMR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,694,263
+$334,952 QoQ
Shares Held
376,503
+5.5% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. LRMR ranks #207 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in LRMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,694,263 | 376,503 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,359,311 | 356,775 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,221,930 | 378,307 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $994,103 | 343,981 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $786,185 | 365,668 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,456,890 | 376,458 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,269,796 | 346,534 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,166,959 | 298,891 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,242,252 | 295,422 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,220,727 | 268,292 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $935,190 | 236,757 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $654,488 | 209,102 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $228,896 | 50,529 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $207,573 | 50,260 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $68,256 | 21,330 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $41,806 | 21,330 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $86,386 | 21,330 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $230,150 | 21,330 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $270,931 | 23,498 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $239,195 | 24,358 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $355,870 | 24,358 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $525,337 | 24,537 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $283,132 | 18,664 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||